Veterinary Medicines

Suvaxyn® Parvo/E

Not authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, strain S-80, Inactivated
Download as PDF

Product identification

Medicine name:
Suvaxyn® Parvo/E
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, strain S-80, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    13.50
    relative potency
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain S-80, Inactivated
    94.10
    haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Zoetis Portugal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Portugal Lda.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • UPD 1.6.1-4 JSON NAP Chpt2 C2 Mandatory 889/01/15RIVPT
Date of authorisation status change: